During the past decade, Clinica Sao Germano conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinica Sao Germano" are "Multiple Myeloma" (9 trials), "Relapsed or Refractory Multiple Myeloma" (2 trials), "Amyloidosis" (1 trials), "Neoplasms" (1 trials) and "Smoldering Multiple Myeloma" (1 trials). Many other conditions were trialed in "Clinica Sao Germano" in a lesser frequency.

Most popular intervention types in "Clinica Sao Germano" are "Drug" (12 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Daratumumab" (6 trials), "Dexamethasone" (6 trials), "Bortezomib" (5 trials), "Lenalidomide" (3 trials) and "Pomalidomide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Sao Germano" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Clinica Sao Germano". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clinica Sao Germano, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Sao Germano, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".